Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
about
Current status of transarterial radioembolizationHow Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsRadioembolization of hepatic tumorsRole of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionRadioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesRadioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Therapeutic strategies for neuroendocrine liver metastases.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).Liver metastases from neuroendocrine tumors.Multimodal liver-directed management of neuroendocrine hepatic metastasesTreatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.Treatment of neuroendocrine tumor liver metastases.Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.Standards of practice in transarterial radioembolization.90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.A Lesion-Based Response Prediction Model Using Pretherapy PET/CT Image Features for Y90 Radioembolization to Hepatic Malignancies.Radioembolization Versus Bland Embolization for Hepatic Metastases from Small Intestinal Neuroendocrine Tumors: Short-Term Results of a Randomized Clinical Trial.Liver transarterial embolizations in metastatic neuroendocrine tumors.Carcinoid-syndrome: recent advances, current status and controversies.Towards new response criteria in neuroendocrine tumors: which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?
P2860
Q26744307-F719DE1D-3625-4AB6-B901-D0BF874D5949Q26764993-E2A3AF9F-A30E-44DC-B85A-EFCD03060E85Q26799046-6BB125A2-097A-4B21-80CA-CD368B2EF49AQ33820777-1BF42A63-0D48-4673-8854-118348055CE6Q34702065-2A08384D-FC2D-4E09-B828-B2C6346A0AD3Q35018379-FC166CEB-F473-47F0-81CA-C66B3012BD5AQ35721324-8094BEF5-5FD5-4A4F-9E76-74D5F7820681Q37125550-DA6B2427-6856-4348-904A-9F0E718F8726Q37525291-AAED110C-CBF7-4A88-BC04-77625674A20EQ38255979-F8356036-B00A-4532-8C4F-DB475213F3FCQ38262113-96911B58-A1D6-43D0-824D-6248F0A4C803Q38264620-F9FB6FB0-675A-4632-9DAA-D64B28720C42Q38283682-959ECA80-54B3-49A9-BD78-905DF826E9C8Q38897797-AC702D2B-B792-4A9F-9F78-74788201DB13Q38956091-F6C5D34D-62E9-4603-8E94-6EB443A4EA97Q40063283-BCF28657-582D-4C16-AAC7-01FCB4BA2FB9Q42287138-E949D9A6-2F0E-4D2A-A8E4-F730EE810DC6Q42355574-9E611899-24A5-4124-AFD1-4204A4187981Q45128821-2B7579B0-2E0E-4560-A021-845820F734B7Q45207818-8A91C1B3-1138-46FA-B7C6-3AD664297A47Q47134709-24825927-D057-456C-8538-D35B5373ACD4Q47208416-76C6092E-F2B3-4483-8EE0-B09655F454FCQ47425435-36EBB51A-FA1F-415F-BAED-ACE1166259E0Q47869784-A4B40E89-61E4-4EE8-A7A5-AF1D9EE3297CQ50094023-22F60BB5-BAE4-435F-89E8-04903C0F251AQ53635873-DFE133D8-F043-43B6-9D7D-C75F1EBAB7ED
P2860
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Radioembolization of symptomat ...... using yttrium-90 microspheres.
@en
type
label
Radioembolization of symptomat ...... using yttrium-90 microspheres.
@en
prefLabel
Radioembolization of symptomat ...... using yttrium-90 microspheres.
@en
P2093
P2860
P1476
Radioembolization of symptomat ...... using yttrium-90 microspheres
@en
P2093
Christoph G Trumm
Franziska Raessler
Gerwin P Schmidt
Maximilian F Reiser
Nima Ashoori
Philipp M Paprottka
Ralf-T Hoffmann
Tobias F Jakobs
Wieland H Sommer
P2860
P2888
P304
P356
10.1007/S00270-011-0248-1
P577
2011-08-17T00:00:00Z
P6179
1027484626